Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

Conditions:   Metastatic Soft Tissue Sarcoma;   Advanced Soft Tissue Sarcoma Intervention:   Drug: doxorubicin with AGEN1884 and AGEN2034 Sponsors:   University of Colorado, Denver;   National Cancer Institute (NCI);   Agenus Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials